ストックスクリーナーアプリを入手
7.64
5.09%
0.37
アフターアワーズ：
7.79
0.15
+1.96%
Cullinan Therapeutics Inc (CGEM) 最新ニュース
Insider Sellers Might Regret Selling Cullinan Therapeutics Shares at a Lower Price Than Current Market Value - simplywall.st
Technical signs of recovery in Cullinan Therapeutics Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser
How to build a custom watchlist for Cullinan Therapeutics Inc.July 2025 Volume & Technical Entry and Exit Tips - Newser
Cullinan Therapeutics Inc. Shows Risk Reward Favoring UpsideEarnings Growth Summary & AI Enhanced Execution Alerts - 선데이타임즈
Will Cullinan Therapeutics Inc. continue its uptrendLong Setup & Weekly Setup with ROI Potential - Newser
Cullinan (CGEM) Q2 R&D Jumps 68% - AOL.com
Does Cullinan Therapeutics Inc. fit your quant trading modelWeekly Market Outlook & Target Return Focused Stock Picks - Newser
How Cullinan Therapeutics Inc. stock performs during market volatilityBull Run & Daily Stock Momentum Reports - Newser
Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionTrend Analysis for Safer Market Entries - Newser
Using data models to predict Cullinan Therapeutics Inc. stock movementEarnings Based Stock Performance Forecast - Newser
Is Cullinan Therapeutics Inc. stock poised for growthFree Fundamental Winners With Safe Entry Plan - Newser
Is Cullinan Therapeutics Inc. showing signs of accumulationMonthly Long-Term Market Recap and Summary - Newser
Full technical analysis of Cullinan Therapeutics Inc. stockFree Swing Trade With Risk Management - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathProven Trading System with Consistent Gains - Newser
Market reaction to Cullinan Therapeutics Inc.’s recent newsTechnical Trade Plan with Entry Checklist - Newser
Is Cullinan Therapeutics Inc. stock reversal real or fakeEntry and Exit Strategy for Swing Traders - Newser
William Blair Has Pessimistic Outlook of CGEM Q3 Earnings - Defense World
Can swing trading help recover from Cullinan Therapeutics Inc. lossesEquity Performance Forecast Based on AI Models - Newser
Key resistance and support levels for Cullinan Therapeutics Inc.Free Value Investing Picks With Stability - Newser
How to track smart money flows in Cullinan Therapeutics Inc.Stock Market Trend and Pattern Analysis - Newser
Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicalsDay Trading Setup and Momentum Analysis - Newser
Cullinan Therapeutics: Q2 Earnings Snapshot - Greenwich Time
Cullinan Therapeutics Reports Q2 2025 Financial Results - TipRanks
What to expect from Cullinan Therapeutics Inc. in the next 30 daysPrice Movement and Market Sentiment Analysis - Newser
Cullinan Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cullinan Therapeutics reports Q2 EPS ($1.07), consensus (86c) - TipRanks
Cullinan Therapeutics Reports Wider-Than-Expected Q2 LossNews and Statistics - IndexBox
Cullinan Therapeutics (CGEM) to Release Earnings on Thursday - Defense World
Cullinan Management Appoints New Board Members - TipRanks
Cullinan Therapeutics Q2 net loss widens to $70.1 mln on higher R&D costs - MarketScreener
Cullinan Therapeutics, Inc. SEC 10-Q Report - TradingView
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - The Manila Times
1.67%
大文字化:
|
ボリューム (24 時間):